| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/30/2001 | CA2400915A1 Estrogen receptor alpha variants and methods of detection thereof |
| 08/30/2001 | CA2400863A1 Staphylococcal gtpase obg nucleotide sequence encoding staphylococcal gtp-binding protein |
| 08/30/2001 | CA2400842A1 Novel compounds |
| 08/30/2001 | CA2400838A1 Novel method for down-regulation of amyloid |
| 08/30/2001 | CA2400831A1 Estrogen receptor beta variants and methods of detection thereof |
| 08/30/2001 | CA2400794A1 New transcription factor carp-2 |
| 08/30/2001 | CA2400710A1 Starch branching enzyme |
| 08/30/2001 | CA2400642A1 Modified fluorescent proteins |
| 08/30/2001 | CA2400636A1 Hybrid cell vaccines |
| 08/30/2001 | CA2400606A1 New phosphodiesterase type 7b |
| 08/30/2001 | CA2400485A1 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |
| 08/30/2001 | CA2400441A1 Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof |
| 08/30/2001 | CA2399550A1 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation |
| 08/30/2001 | CA2398275A1 Human polynucleotides, polypeptides, and antibodies |
| 08/30/2001 | CA2397705A1 Compounds related to or derived from gfr.alpha.4 and their use |
| 08/29/2001 | EP1127942A1 Method of immortalization of human keratinocytes by down-regulation of 14-3-3 sigma expression |
| 08/29/2001 | EP1127893A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 08/29/2001 | EP1127577A2 Ligand for the c-kit receptor and methods of use thereof |
| 08/29/2001 | EP1127576A1 Uses of NM23-polypeptides in skin and intestinal disorders |
| 08/29/2001 | EP1127487A1 Adult t cell leukemia model animal |
| 08/29/2001 | EP1127486A1 A method for production of a transgenic animal |
| 08/29/2001 | EP1127482A2 Apparatus for culturing plantlets and process for culturing plantlets by using said apparatus |
| 08/29/2001 | EP1127170A1 Human pan-hcv human monoclonal antibodies |
| 08/29/2001 | EP1127169A1 Detection of negative-strand rna viruses |
| 08/29/2001 | EP1127160A2 Parallel methods for genomic analysis |
| 08/29/2001 | EP1127157A1 METHYLATED CpG ISLAND AMPLIFICATION (MCA) |
| 08/29/2001 | EP1127151A2 Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors |
| 08/29/2001 | EP1127150A2 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| 08/29/2001 | EP1127149A2 Cells for the production of helper dependent adenoviral vectors |
| 08/29/2001 | EP1127146A2 Novel expression cassette for expressing genes in plant seed |
| 08/29/2001 | EP1127140A2 Fk506-based regulation of biological events |
| 08/29/2001 | EP1127138A1 Alpha 1,2 fucosyltransferase from helicobacter pylori |
| 08/29/2001 | EP1127136A1 Delivery of superoxide dismutase to neuronal cells |
| 08/29/2001 | EP1127135A2 High fidelity thermostable ligase and uses thereof |
| 08/29/2001 | EP1127134A1 Rotavirus subunit vaccine |
| 08/29/2001 | EP1127133A2 Polypeptide mediating cell permeability |
| 08/29/2001 | EP1127132A1 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock |
| 08/29/2001 | EP1127131A2 Connective tissue growth factor (ctgf) and methods of use |
| 08/29/2001 | EP1127129A1 Myosin heavy chain homolog |
| 08/29/2001 | EP1127128A1 Isolated vshk-1 receptor polypeptides and methods of use thereof |
| 08/29/2001 | EP1127125A1 Methods for transforming plants to express bacillus thuringiensis delta-endotoxins |
| 08/29/2001 | EP1127124A2 Novel compositions and methods of screening for t-cell and b-cell activation modulators |
| 08/29/2001 | EP1127123A2 Cell surface glycoproteins |
| 08/29/2001 | EP1127120A1 Genomic and complete cdna sequences of human adipocyte-specific apm1 and biallelic markers thereof |
| 08/29/2001 | EP1127119A1 Compounds and methods for modulating claudin-mediated functions |
| 08/29/2001 | EP1127117A1 Opg fusion protein compositions and methods |
| 08/29/2001 | EP1127113A2 Transgenic and cloned mammals |
| 08/29/2001 | EP1127112A2 Methods for cloning animals |
| 08/29/2001 | EP1127110A1 Modified exosomes and uses |
| 08/29/2001 | EP1127109A2 The genetic determination of genes and its use for the prophylaxis and therapy of diseases |
| 08/29/2001 | EP1127108A2 Method for producing dendritic cells |
| 08/29/2001 | EP1127107A1 Methods for the production of tcr gamma delta t cells |
| 08/29/2001 | EP1127106A1 Glufosinate tolerant rice |
| 08/29/2001 | EP1127104A1 Method for the massive culture of cells producing recombinant human erythropoietin |
| 08/29/2001 | EP1127076A2 Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof |
| 08/29/2001 | EP1127075A2 A method of treating tumors using fas-induced apoptosis |
| 08/29/2001 | EP1127074A1 Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with rage |
| 08/29/2001 | EP1127072A1 Method for detecting and purifying tcd8+ lymphocyte populations, specific of peptides present in the context of hla |
| 08/29/2001 | EP1127069A2 Biological materials and methods useful in the diagnosis and treatment of prion diseases |
| 08/29/2001 | EP1127068A1 Immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 08/29/2001 | EP1127067A2 Inhibition of transglutaminase-mediated microbial interaction with a mammalian host |
| 08/29/2001 | EP1127066A1 Modified proteins |
| 08/29/2001 | EP1127065A2 $i(chlamydia) antigens and corresponding dna fragments and uses thereof |
| 08/29/2001 | EP1127064A1 Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof |
| 08/29/2001 | EP1126878A1 Heparanase activity neutralizing anti-heparanase monoclonal antibody |
| 08/29/2001 | EP1126873A1 Method for enhancing proliferation of inner ear hair cells using ligands for her2 and/or her3 receptors |
| 08/29/2001 | EP1126872A1 CANCER IMMUNOTHERAPHY AND DIAGNOSIS USING UNIVERSAL TUMOR ASSOCIATED ANTIGENS, INCLUDING hTERT |
| 08/29/2001 | EP1126863A1 Vascular endothelial growth factor-like protein from orf virus nz2 binds and activates mammalian vegf receptor-2 |
| 08/29/2001 | EP1126859A2 Blood leucocyte apheresis for treatment of disease |
| 08/29/2001 | EP1126858A1 Production of a biological factor and creation of an immunologically privileged environment using genetically altered sertoli cells |
| 08/29/2001 | EP0914043A4 Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof |
| 08/29/2001 | EP0751709B1 Use of bcl-2 for the manufacture of medicaments for the therapeutic treatment and prevention of diseases |
| 08/29/2001 | CN1310761A Enzyme |
| 08/29/2001 | CN1310760A Methods and compositions for expression of transgenes in plants |
| 08/29/2001 | CN1310759A Therapeutic and diagnostic domain 1 & beta 2GP1 polypeptides and methods of using same |
| 08/29/2001 | CN1310757A Novel mannanases |
| 08/29/2001 | CN1310755A Transferring materials into cells using porous silicon |
| 08/29/2001 | CN1070198C Isolated nucleic acid molecule of coded tumor rejection antigen precursor DAGE and its application |
| 08/29/2001 | CA2335436A1 Novel core 2 beta-1,6-n-acetylglycosaminyl transferase gene |
| 08/28/2001 | US6281375 Biodegradable high oxidative stability oils |
| 08/28/2001 | US6281348 A dna encoding a gene that inhibits pollen formation; producing hybrid seeds for commercial sale |
| 08/28/2001 | US6281335 Hybridoma and anti-KC-4 humanized monoclonal antibody |
| 08/28/2001 | US6281332 Hedgehog-derived polypeptides |
| 08/28/2001 | US6281330 Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor |
| 08/28/2001 | US6281257 Porous composite materials |
| 08/28/2001 | US6281017 A nucleic acid molecule; involved in the producution of intermediates to isoprenoids |
| 08/28/2001 | US6281016 Broad-spectrum insect resistant transgenic plants |
| 08/28/2001 | US6281015 Introducing a microsphere with a bioactive factor to a hepatocyte seeded biodegradable polymer matrix into a transplantation site; enhancing survival and proliferation of transplanted cells |
| 08/28/2001 | US6281013 In vitro fertilization; treating female with hypothalamic or pituitary hormone, retrieving oocyte, exposure to meiosis activating substance |
| 08/28/2001 | US6281012 Preventing graft versus host disease |
| 08/28/2001 | US6281011 Random fragmentation of dna; transferring to expression vector; screening or selecting suppression |
| 08/28/2001 | US6281010 Gene expression, engineering; packaging transgene; genetic disorders |
| 08/28/2001 | US6281007 Exposing biopolymer to maturation fluid; applying transverse force; strengthening |
| 08/28/2001 | US6280997 Isolated nucleic acid molecule which codes for a 32 KDA protein having 11-CIS retinol dehydrogenase activity, and which associates with P63, a portion of a retinol binding protein receptor |
| 08/28/2001 | US6280971 Polynucleotide associated with detection of staphylococcus; for use in screening bactericides |
| 08/28/2001 | US6280970 Bird embryonic tissues; for use as diagnostic diagnostic tools or in vaccine development |
| 08/28/2001 | US6280940 Reporter gene system for use in cell-based assessment of inhibitors of the Hepatitis C virus protease |
| 08/28/2001 | US6280928 Mixed cell diagnostic systems |
| 08/28/2001 | US6280760 Peptide-coated implants and methods for producing same |
| 08/28/2001 | US6280735 Polypeptides of riboflavin specific deaminase family |